Neuropsychiatric adverse effects of antihistamine: A nationwide data-based epidemiological study in South Korea
Asian Pacific Journal of Allergy and Immunology · 2026
DOI: 10.12932/ap-100724-1889 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Pacific Journal of Allergy and Immunology, 2026. Verfasst von Jin Youp Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology-Head and Neck Surgery, Ilsan Hospital, Dongguk University, Goyang, Gyeonggi, South Korea. Hauptthemen laut MEDLINE: Mental Disorders, Histamine Antagonists, Hypersensitivity.
Abstract (Originalsprache)
BACKGROUND: Despite concerns on the major neuropsychiatric side effects for long-term use of H1-receptor antagonist (anti-histamine, AH), one of the major therapeutic tools for allergic diseases, their association has not been investigated well. OBJECTIVE: This study aimed to assess the association between AH usage and neuropsychiatric disorder (NPD) incidence using the National Health Insurance Service Database. METHODS: This study was conducted using data from the National Health Insurance Service Database from January 1st 2002 through December 31th 2017. To enroll the participants who may have history of long-term use of AH, participants having common allergic diseases were enrolled. We defined NPD as diagnosed by a psychiatrist occurring during and after antihistamine use to 6 months thereafter. RESULTS: A total of 1,488,075 participants were enrolled. No significant association was found between increased AH usage and NPD incidence after adjusting for potential confounding factors in the health screening data. Notably, the 30-89 day AH usage group showed a significantly lower NPD risk in the subgroup analysis in participants aged over 60 years. No other groups within this age category showed a significant increase in risk. CONCLUSIONS: This study suggests that long-term AH use does not significantly increase NPD risk. While this study lacked evaluation of mild neuropsychiatric side effects not requiring psychiatric visits, this study may contribute real-world evidence to the understanding of AHs' long-term neuropsychiatric side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology-Head and Neck Surgery, Ilsan Hospital, Dongguk University, Goyang, Gyeonggi, South Korea.
- Interdisciplinary Program of Medical Informatics, Seoul National University College of Medicine, Seoul, South Korea.
- Sensory Organ Research Institute, College of Medicine, Dongguk University, Gyengju, South Korea.
- Department of Family Medicine & Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
- Department of Clinical Research Design and Evaluation/Department of Digital Health, Samsung Advanced Institute of Health Science and Technology (SAIHST), Sungkyunkwan University, Seoul, South Korea.
- Interdisciplinary Program of Bioengineering, Seoul National University College of Engineering, Seoul, Republic of Korea.
Zitieren
APA
Kim, J. Y., Shin, D. W., Kim, Z., Kim, S. H., Son, K. L., Kim, S. H., & Yoon, H. J. (2026). Neuropsychiatric adverse effects of antihistamine: A nationwide data-based epidemiological study in South Korea. Asian Pacific Journal of Allergy and Immunology. https://doi.org/10.12932/ap-100724-1889
Vancouver
Kim JY, Shin DW, Kim Z, Kim SH, Son KL, Kim SH, et al. Neuropsychiatric adverse effects of antihistamine: A nationwide data-based epidemiological study in South Korea. Asian Pacific Journal of Allergy and Immunology. 2026. doi:10.12932/ap-100724-1889
BibTeX
@article{Kim2026,
author = {Kim, Jin Youp and Shin, Dong Wook and Kim, Zio and Kim, Su Hwan and Son, Kyung-Lak and Kim, Su Hwan and Yoon, Hyung-Jin},
title = {Neuropsychiatric adverse effects of antihistamine: A nationwide data-based epidemiological study in South Korea},
journal = {Asian Pacific Journal of Allergy and Immunology},
year = {2026},
doi = {10.12932/ap-100724-1889}
}
EUVIMED